# LGC acquires Technopath Clinical Diagnostics

LGC announced its acquisition of Technopath Clinical Diagnostics, expanding LGC's position in the clinical diagnostics QC market. Technopath's chemistry and immunoassay controls will be integrated into LGC's clinical diagnostics business unit.

- Type: Acquisition
- Announced: 2021-03-01
- Where: Ireland
- Status: completed
- Products: quality control products for clinical diagnostics
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [LGC Limited](https://endata.com/companies/30264.md) (acquirer)
- [Technopath Clinical Diagnostics](https://endata.com/companies/30775.md) (target)

## Sources

- [captodayonline.com](https://www.captodayonline.com/lgc-acquires-technopath/), 2021-03-19: "Technopath's multiconstituent quality control products will dovetail perfectly with the calibration verification, molecular, and serology product portfolios within our clinical diagnostics business."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.